| Financial Year |
March 31 2023 |
| Monetary Funds |
1,096,813,021.14 |
| Held-for-trading Financial Assets |
2,064,549.12 |
| Notes Receivable |
3,055,737.50 |
| Accounts Receivable |
169,831,454.14 |
| Advances to Suppliers |
2,112,000.75 |
| Other Receivables |
10,798,343.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
336,187,177.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,418,629.08 |
| Total Current Assets |
1,677,280,912.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
262,773,273.93 |
| Under-construction Projects |
717,608,076.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,496,647.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,237,591.26 |
| Other Non-Current Assets |
16,360,433.98 |
| Sub-Total of Non-Current Assets |
1,225,118,273.88 |
| Total Assets |
2,902,399,186.71 |
| Short-Term Loans |
250,252,273.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
155,844,770.76 |
| Accounts Payable |
310,154,195.40 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,450,249.25 |
| Taxes Payable |
19,063,233.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,445,436.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,108,915.86 |
| Other Current Liabilities |
22,813.27 |
| Sub-Total of Current Liabilities |
765,660,150.14 |
| Long-term Loans |
72,744,479.75 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,220,872.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
108,103,527.13 |
| Total Liabilities |
873,763,677.27 |
| Paid-In Capital(Or Share Stock) |
423,620,992.00 |
| Capital Surplus |
846,901,502.82 |
| Surplus Reserve |
76,597,029.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
682,459,949.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,028,635,509.44 |
| Owner's Equity（Stockholder's Equity） |
2,028,635,509.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,902,399,186.71 |
